EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

First nationwide survey on Pseudomonas aeruginosa in Bolivia: susceptibility profiles, resistome, and genomic epidemiology

Neisa Alvarado-Orosco, Maria A Gomis-Font iD, Miquel A Sastre-Femenia, Silvia Ribera Ortiz, Maritza Miranda Arce, María Elena Araúz Barba, María Del Rosario Navia Durán, Sandra Grisel Vargas Nattez, Gabriela Cabellos Astorga, Paola Janeth Villarroel Rodriguez, Damariz Daniela Almaraz Roca, Marleni Castillo Cruz und 9 weitere

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.01163-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Neisa Alvarado-Orosco und 20 weiteren Autor:innen. Beteiligte Einrichtung: UF of Bacteriology, National Center for Tropical Diseases (CENETROP), Santa Cruz de la Sierra, Bolivia. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Anti-Bacterial Agents, Pseudomonas Infections, Drug Resistance, Multiple, Bacterial. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación (MCI) de España y el programa NextGenerationEU, National Center for Tropical Diseases (CENETROP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Information on the molecular epidemiology of Pseudomonas aeruginosa and antimicrobial resistance mechanisms is still limited in some South American countries. This study aims to decipher the population structure of 111 extensive drug-resistant P. aeruginosa isolates from a national study conducted in Bolivia during 2023–2024. The antibiotic susceptibility profiles were determined for 15 antipseudomonal agents. All isolates were subjected to whole-genome sequencing (WGS), and, through bioinformatics analysis, sequence types (ST), clonal relatedness, and acquired mutation-driven and transferable resistance mechanisms were elucidated. The most active antipseudomonal agents were colistin (98.2% intermediate, MIC 50/90 =1/2 mg/L) and cefiderocol (92.7% susceptible, MIC 50/90 =0.25/4 mg/L) according to the Clinical and Laboratory Standards Institute (CLSI). High resistance rates to ceftazidime/avibactam (79.3%), ceftolozane/tazobactam (82.9%), and imipenem/relebactam (71.2%) were documented. Carbapenemases were found in 60.3%, particularly including metallo-β-lactamases (MBL), such as SPM-1 (35%), VIM-2 (9%), the co-production of NDM-1 and DIM-1 (4%), or the new IMP variant IMP-111. Extended-spectrum β-lactamases (ESBLs) were detected in 12% of the isolates, including OXA-17 (7%), PER-1 (3%), and some GES variants. The most commonly detected clone was ST277 (35%) associated with SPM-1, followed by the ST309 (25%) producer of OXA-2 and various GES, and ST235 (20%) related with OXA-17 and new IMP-111. These clones harbored other acquired resistance genes, including emerging 16S rRNA methyltransferases, RmtD and RmtG. The high resistance rates for novel beta-lactams linked to an alarming spread of high-risk clones ST277 and ST235 and the very high prevalence of MBLs and ESBLs raise significant concern. This underscores the urgent need for establishing epidemiological surveillance and infection control strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaAnti-Bacterial AgentsPseudomonas InfectionsDrug Resistance, Multiple, BacterialBoliviaMicrobial Sensitivity TestsHumansWhole Genome Sequencingbeta-LactamasesCephalosporinsMolecular EpidemiologyColistinCeftazidimeTazobactamBacterial ProteinsAzabicyclo CompoundsImipenem

Stichwörter der Autor:innen

Pseudomonas aeruginosaantimicrobial resistancegenomic epidemiology

Substanzen

Anti-Bacterial Agentsbeta-LactamasesCephalosporinsColistinCeftazidimeTazobactamBacterial ProteinsAzabicyclo Compoundsceftolozane, tazobactam drug combinationImipenem

Autor:innen und Institutionen

  • UF of Bacteriology, National Center for Tropical Diseases (CENETROP), Santa Cruz de la Sierra, Bolivia.
  • Department of Microbiology, Hospital Universitario Son Espases, Instituto de Investigación Sanitaria Islas Baleares (IdISBa), CIBERINFEC, Palma, Spain.
  • Microbiology Laboratory, Hospital San Juan de Dios, Santa Cruz de la Sierra, Bolivia.
  • Department of Bacteriology, Hospital Universitario Japonés, Santa Cruz de la Sierra, Bolivia.
  • Microbiology Laboratory, Hospital Obrero N. 3, Santa Cruz de la Sierra, Bolivia.
  • Microbiology, Hospital Santa Bárbara, Sucre, Bolivia.

ORCID-Profile: Maria A Gomis-Font, Carla López-Causapé, Antonio Oliver

Förderung

  • Ministerio de Ciencia e Innovación (MCI) de España y el programa NextGenerationEU
  • National Center for Tropical Diseases (CENETROP)

Zitieren

APA

Alvarado-Orosco, N., Gomis-Font, M. A., Sastre-Femenia, M. A., Ribera Ortiz, S., Miranda Arce, M., Araúz Barba, M. E., Navia Durán, M. R., Vargas Nattez, S. G., Cabellos Astorga, G., Villarroel Rodriguez, P. J., Almaraz Roca, D. D., Castillo Cruz, M., Chambi Condori, J. P., Quevedo Ribera, P., Patino García, S. M., Contreras Otalora, Y., Rosales Rea, F. M., Portugal Gutiérrez, C. M., Sánchez Serrano, M., …, & Oliver, A. (2025). First nationwide survey on Pseudomonas aeruginosa in Bolivia: susceptibility profiles, resistome, and genomic epidemiology. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01163-25

Vancouver

Alvarado-Orosco N, Gomis-Font MA, Sastre-Femenia MA, Ribera Ortiz S, Miranda Arce M, Araúz Barba ME, et al. First nationwide survey on Pseudomonas aeruginosa in Bolivia: susceptibility profiles, resistome, and genomic epidemiology. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01163-25

BibTeX
@article{AlvaradoOrosco2025,
  author = {Alvarado-Orosco, Neisa and Gomis-Font, Maria A and Sastre-Femenia, Miquel A and Ribera Ortiz, Silvia and Miranda Arce, Maritza and Araúz Barba, María Elena and Navia Durán, María Del Rosario and Vargas Nattez, Sandra Grisel and Cabellos Astorga, Gabriela and Villarroel Rodriguez, Paola Janeth and Almaraz Roca, Damariz Daniela and Castillo Cruz, Marleni and Chambi Condori, Juan Pablo and Quevedo Ribera, Pedro and Patino García, Suan Mishelly and Contreras Otalora, Yenny and Rosales Rea, Flor María and Portugal Gutiérrez, Claudia Milena and Sánchez Serrano, Marisol and López-Causapé, Carla and Oliver, Antonio},
  title = {First nationwide survey on Pseudomonas aeruginosa in Bolivia: susceptibility profiles, resistome, and genomic epidemiology},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.01163-25}
}
Kostenlos starten →